Boston Partners’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350M | Sell |
4,989,924
-46,721
| -0.9% | -$3.28M | 0.39% | 82 |
|
|
2025
Q1 | $369M | Buy |
5,036,645
+1,329,166
| +36% | +$97.3M | 0.45% | 73 |
|
|
2024
Q4 | $243M | Buy |
3,707,479
+3,670,719
| +9,986% | +$241M | 0.3% | 131 |
|
|
2024
Q3 | $2.86M | Buy |
36,760
+32,814
| +832% | +$2.56M | ﹤0.01% | 478 |
|
|
2024
Q2 | $309K | Sell |
3,946
-544
| -12% | -$42.6K | ﹤0.01% | 687 |
|
|
2024
Q1 | $309K | Buy |
+4,490
| New | +$309K | ﹤0.01% | 733 |
|
|
2023
Q4 | – | Sell |
-3,107
| Closed | -$210K | – | 712 |
|
|
2023
Q3 | $210K | Buy |
3,107
+57
| +2% | +$3.86K | ﹤0.01% | 701 |
|
|
2023
Q2 | $218K | Sell |
3,050
-585
| -16% | -$41.9K | ﹤0.01% | 686 |
|
|
2023
Q1 | $252K | Buy |
+3,635
| New | +$252K | ﹤0.01% | 660 |
|
|
2014
Q1 | – | Sell |
-331,935
| Closed | -$19.7M | – | 719 |
|
|
2013
Q4 | $19.7M | Sell |
331,935
-2,294,117
| -87% | -$136M | 0.04% | 283 |
|
|
2013
Q3 | $136M | Buy |
2,626,052
+2,532,101
| +2,695% | +$131M | 0.33% | 97 |
|
|
2013
Q2 | $4.44M | Buy |
+93,951
| New | +$4.44M | 0.01% | 497 |
|